ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study

March 28, 2014

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Cancer Incidence Rates Climb In HIV-Positive Female Populations

April 27, 2012

Sam Broder Receives Arthur Flemming Award

June 1, 1984

Agriculture Dept. Asks clearinghouse To Consider Broader Risk Assessment Data

July 14, 1978

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014